Melanie P. Matheu

Department of Physiology and Biophysics

University of California, Irvine (UCI)

Dr. Melanie Matheu is the founder of Prellis Biologics. Dr. Matheu studied immunology for 15 years and authored numerous peer-reviewed publications and a book chapter detailing methods and approaches for high-resolution imaging in tissues before starting Prellis Biologics in October 2016. She was inspired to find a way to reverse-engineer laser-based imaging systems into a printer when she realized that the final roadblock in engineering human tissue and organs for transplant was a simple and well-defined engineering problem: how can microvasculature be printed fast enough to build human tissues? Prellis Biologics' technology solves this problem by partially decoupling printing speed from resolution with a novel patent-pending laser based projection system.

我们使用 cookie 来增强您在我们网站上的体验。

继续使用我们的网站或单击“继续”,即表示您同意接受我们的 cookie。